Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rebys (HSP Gp96 vaccine) / Cure & Sure Biotech
NCT03650257: A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96	Recruiting	2	150	RoW	gp96, Heat Shock, HSPPC-96, Temozolomide, TZM, radiotherapy	Cure&Sure Biotech Co., LTD, Beijing Tiantan Hospital, Shenzhen Second People's Hospital	Glioma of Brain	08/21	08/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rebys (HSP Gp96 vaccine) / Cure & Sure Biotech
NCT03650257: A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96	Recruiting	2	150	RoW	gp96, Heat Shock, HSPPC-96, Temozolomide, TZM, radiotherapy	Cure&Sure Biotech Co., LTD, Beijing Tiantan Hospital, Shenzhen Second People's Hospital	Glioma of Brain	08/21	08/24